Evidence map›Paper›PMID 15946246›Full record

ReviewImmunology2005

Close encounters of the monoamine kind: immune cells betray their nervous disposition.

Elizabeth J Meredith, Anita Chamba, Michelle J Holder, Nicholas M Barnes, John Gordon

Registry-linked trialAbstract readReview
In one paragraph

Review in Immunology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01650311 (Investigating Serotonin Signalling in IBD Patients), which is not on this map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01650311 recruitingnot on this mapstarted 2012, after this paper: background citation

Investigating Serotonin Signalling in IBD Patients

TypeobservationalSponsorMcMaster UniversityRan2012 to 2026Enrolled60ConditionsInflammatory Bowel Disease
3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Review
  2. Article
  3. Dopamine, Immunity, and Disease.Pharmacological reviews · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. The Effects of Serotonin in Immune Cells.Frontiers in cardiovascular medicine · 2017
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elizabeth J MeredithMRC Centre for Immune Regulation, The Medical School, University of Vincent Drive, Birmingham B15 2TT, UK.
Anita Chamba
Michelle J Holder
Nicholas M Barnes
John Gordon

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here we review the evidence for immune cells expressing multiple components of the serotonergic and dopaminergic systems that are more commonly associated with the central nervous system (CNS). We discuss where and how peripheral encounters with these biogenic monoamines occur and posit reasons as to why the immune system would wish to deploy these pathways. A full taxonomy of serotonergic and dopaminergic constituents and their workings in component cells of the immune system should facilitate the formulation of novel therapeutic approaches in diseases characterized by immune dysfunction and potentially provide a range of surrogate peripheral markers for registering and monitoring disturbances within the CNS.

Indexed as

Central Nervous SystemDopamineDopamine Plasma Membrane Transport ProteinsEnterochromaffin CellsHumansLymphocytesLymphoid TissueMembrane GlycoproteinsMembrane Transport ProteinsModels, ImmunologicalNerve Tissue ProteinsReceptors, DopamineReceptors, SerotoninSerotoninSerotonin Plasma Membrane Transport ProteinsDopamineDopamine Plasma Membrane Transport ProteinsMembrane GlycoproteinsMembrane Transport ProteinsNerve Tissue ProteinsReceptors, DopamineReceptors, SerotoninSerotoninSerotonin Plasma Membrane Transport ProteinsSLC6A4 protein, human

Identifiers

PMID15946246
PMCPMC1782168

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.